Cargando…

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study

BACKGROUND: Middle-income countries (MICs) that are not eligible for funding from Gavi, the Vaccine Alliance, have been slow to adopt rotavirus vaccines. Few studies have evaluated the cost-effectiveness and benefit–risk of rotavirus vaccination in these settings. We aimed to assess the potential ec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debellut, Frédéric, Clark, Andrew, Pecenka, Clint, Tate, Jacqueline, Baral, Ranju, Sanderson, Colin, Parashar, Umesh, Atherly, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205857/ https://www.ncbi.nlm.nih.gov/pubmed/33891885 http://dx.doi.org/10.1016/S2214-109X(21)00167-4

Ejemplares similares

Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2019)

Health and economic impact of rotavirus vaccination in GAVI-eligible countries
por: Kim, Sun-Young, et al.
Publicado: (2010)

Impact and cost-effectiveness of rotavirus vaccination in Bangladesh
por: Pecenka, Clint, et al.
Publicado: (2017)

Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates
por: Baral, Ranju, et al.
Publicado: (2020)

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules
por: Clark, Andrew, et al.
Publicado: (2019)

The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models
por: Baral, Ranju, et al.
Publicado: (2020)

Estimating the global impact of rotavirus vaccines on child mortality
por: Clark, Andrew, et al.
Publicado: (2023)

Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries
por: Mahmud, Sarwat, et al.
Publicado: (2023)

Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia
por: Lusvan, Munkh-Erdene, et al.
Publicado: (2019)

Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2022)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
por: Pecenka, Clint, et al.
Publicado: (2018)

Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective
por: Wittenauer, Rachel, et al.
Publicado: (2023)

Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model
por: Baral, Ranju, et al.
Publicado: (2021)

Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines
por: Debellut, Frédéric, et al.
Publicado: (2022)

Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2018)

Economic evaluation of rotavirus vaccination in children of Bhutan
por: Pempa, et al.
Publicado: (2020)

Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
por: Pecenka, Clint, et al.
Publicado: (2020)

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country
por: Burger, Emily A., et al.
Publicado: (2018)

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
por: Steele, A.D., et al.
Publicado: (2019)

Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines
por: Hausdorff, William P., et al.
Publicado: (2022)

Removing the Age Restrictions for Rotavirus Vaccination: A Benefit-Risk Modeling Analysis
por: Patel, Manish M., et al.
Publicado: (2012)

Comparative evaluation of the potential impact of rotavirus versus hpv vaccination in GAVI-eligible countries: A preliminary analysis focused on the relative disease burden
por: Kim, Sun-Young, et al.
Publicado: (2011)

Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage
por: Baral, Ranju, et al.
Publicado: (2020)

Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient–Level Costing Data
por: Bar-Zeev, Naor, et al.
Publicado: (2016)

Cost-effectiveness of rotavirus vaccination in Mozambique
por: Lourenço Guimarães, Esperança, et al.
Publicado: (2022)

The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease
por: Glass, Roger I, et al.
Publicado: (2021)

Global rotavirus vaccine introductions and coverage: 2006 – 2016
por: Abou-Nader, Alice J., et al.
Publicado: (2018)

Global Experience With Rotavirus Vaccines
por: Burke, Rachel M, et al.
Publicado: (2021)

Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031
por: Nonvignon, Justice, et al.
Publicado: (2018)

Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC
por: Debellut, Frédéric, et al.
Publicado: (2020)

Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials
por: Clark, Andrew, et al.
Publicado: (2019)

Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries
por: Debellut, Frédéric, et al.
Publicado: (2018)

Current and new rotavirus vaccines
por: Burke, Rachel M., et al.
Publicado: (2019)

Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness
por: Owusu, Richmond, et al.
Publicado: (2023)

Exploring the influence of the Global Fund and the GAVI Alliance on health systems in conflict-affected countries
por: Patel, Preeti, et al.
Publicado: (2015)

93. Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination: the United States, 2000–2018
por: Hallowell, Benjamin D, et al.
Publicado: (2019)

Trends in the Burden and Seasonality of Rotavirus in the United States, 2000–2016
por: Aliabadi, Negar, et al.
Publicado: (2017)

The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study
Publicado: (2019)

Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination — United States, 2000–2018
por: Hallowell, Benjamin D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q2hlmsodq3gsthlg8vsnogom62